New hope for hard-to-treat cancers? utidelone tested in advanced solid tumors
Disease control
Completed
This study tested the drug utidelone in 126 people with advanced solid tumors (like head and neck, stomach, or ovarian cancer) that had stopped responding to standard treatments or could not be treated with them. The goal was to see if the drug could shrink tumors and how safe it…
Phase: PHASE2 • Sponsor: Beijing Biostar Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC